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Abstract The putative Rab3 effector RIM (Rab3-interacting
molecule) was detected by Northern blotting, RT-PCR and
Western blotting in native pancreatic L-cells as well as in the
derived cell lines INS-1E and HIT-T15. RIM was localized on
the plasma membrane of INS-1E cells and L-cells. An
involvement of RIM in insulin exocytosis was indicated by
transfection experiments of INS-1E cells with the Rab3 binding
domain of RIM. This domain enhanced glucose-stimulated
secretion in intact cells and Ca2+-stimulated exocytosis in
permeabilized cells. Co-expression of Rab3A reversed the effect
of RIM on exocytosis. These results suggest an implication of
RIM in the control of insulin secretion.
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1. Introduction
In the pancreatic L-cell, insulin is stored in large dense core
vesicles (secretory granules) and is released by exocytosis in a
Ca2-dependent manner [1]. This process shares many char-
acteristics with neurotransmitter release [2,3]. In this context,
monomeric Rab GTPases constitute a large protein family
implicated in the vectorial movement of vesicles in the secre-
tory pathway [4,5]. They act as molecular switches that £ip
between two conformational states, the active GTP-bound
form and the inactive GDP-bound form [4^6]. In particular,
Rab3 seems to control exocytosis, thus Rab3A de¢cient mice
exhibit enhanced neurotransmitter release [7]. Not only
Rab3A, but also Rab3B, -C and -D are expressed in insu-
lin-secreting cells and in part associated with the secretory
granules [8,9]. The reversible association with the membrane
of secretory vesicles, as well as guanine nucleotide binding and
the GTPase activity of Rab3, are under the control of several
regulatory proteins and e¡ectors such as rabphilin-3A [10] and
Rab3-interacting molecule RIM [11]. Using a yeast two-hy-
brid selection, RIM was identi¢ed from a rat brain cDNA
library. RIM is composed of an N-terminal Rab3A binding
zinc-¢nger motif, followed by an alanine/proline-rich se-
quence. The central portion of the protein contains a PDZ
domain mediating the attachment to plasma membrane pro-
teins [12]. Two C-terminal atypical C2 domains are separated
by alternatively spliced sequences [11]. In rabphilin-3A two
typical C-terminal C2 domains are present, which bind phos-
pholipid in a Ca2-dependent manner [10]. There is no con-
clusive evidence that rabphilin-3A is expressed in primary L-
cells and furthermore rabphilin-3A knock-out mice display a
normal phenotype [13]. However the implication of RIM in
regulated exocytosis is suggested by two observations: (i)
RIM is restricted to the active zone in the presynaptic mem-
brane, where vesicles dock, and (ii) overexpression of the
Rab3A binding domain of RIM in PC12 cells enhances regu-
lated exocytosis in a Rab3-dependent manner [11]. Based on
Northern blotting of various tissues, RIM was proposed to be
expressed exclusively in brain [11]. Here we demonstrate the
expression of RIM and its function in pancreatic L-cells and
derived cell lines.
2. Materials and methods
2.1. Materials
The plasmids encoding the full-length RIM (pCMV-RIM) and the
GST-RIM fusion protein (pGEX-RIM-52) were generously provided
by Dr. T.C. Su«dhof (Southwestern Medical Center at Dallas, Univer-
sity of Texas). The cDNA coding for human growth hormone was
obtained from Dr. J. Lang and Dr. H. Zhang (Department of Clinical
Biochemistry, University of Geneva). The mouse monoclonal anti-
body speci¢c for human c-myc (9E10) was produced from myeloma
SP2/O and the supernatant from the hybridoma was used for experi-
ments.
2.2. Pancreatic islets
Rat pancreatic islets were obtained as described [14]. Islet cells were
then separated into two populations, non-L- and L-cells, by £uores-
cence-activated cell sorter (FACS) as described [14] and the latter were
used for RT-PCR experiments. Alternatively, following the Ficoll
gradient, islet cells were cultured on poly-ornithine-coated glass cover-
slips and used for immuno£uorescence experiments as reported [14].
Human pancreatic islets were isolated by collagenase digestion and
cultured free £oating in CMRL-1066 medium with 10% FCS prior to
the experiments [15].
2.3. Generation of the soluble N-terminal portion of RIM
The nucleotides coding for the residues 1^399 of RIM were inserted
in a myc-tagged expression vector derived from pcDNA3 (Invitrogen,
San Diego, CA, USA) by the following procedure. First, nucleotides
corresponding to the residues 1^10 were inserted in the myc-tagged
pcDNA3, then the fragment coding for residues 11^398 (excised from
pGEX-RIM-52) was added, and ¢nally the residue 399 was generated
by site-directed mutagenesis (QuikChange site-directed mutagenesis
kit, Stratagene, Basel, Switzerland). The obtained construct was con-
¢rmed by DNA sequencing of the plasmid.
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2.4. Northern blotting and RT-PCR
For Northern blotting total RNA was extracted from whole rat
brain and insulin-secreting cell lines cultured in 10-cm dishes by the
guanidinium thiocyanate/phenol/chloroform method [16]. Poly A
mRNA was puri¢ed from 250 Wg of total RNA (Oligotex mRNA,
Qiagen AG, Basel, Switzerland), denatured with glyoxal and di-
methylsulphoxide and separated on 1% agarose gels. Resolved RNA
was blotted to nylon membrane by vacuum transfer (VacuGene XL,
Pharmacia, Uppsala, Sweden), followed by UV cross-linking. The
membrane was hybridized to 32P-labelled cDNA probe derived from
the full-length RIM cDNA (pCMV-RIM), using the random priming
technique (Boehringer, Mannheim, Germany).
For RT-PCR total RNA was extracted from rat kidney, rat brain,
primary L-cells puri¢ed by FACS and cell lines by the use of Trizol
(Gibco Life Sciences, Basel, Switzerland). Reverse transcription was
done with an input of 1 Wg total RNA using AMV reverse transcrip-
tase (Promega, Catalys AG, Wallisellen, Switzerland). The primers
used for reverse transcription and ampli¢cation of rat kidney, brain,
islet L-cells and INS-1E cDNAs were: 5P-GTTCAGTGATTTCCTT-
GATGGG-3P (sense strand, positions 4542^4563 of RIM cDNA se-
quence in reference [16]) and 5P-TTACTATGACCGGATGCAGGG-
3P (antisense strand, positions 5059^5079). The following primers were
used for ampli¢cation of HIT-T15 cDNA: 5P-ACGTCAGATG-
TCGGTGAGCA-3P (sense strand, positions 2031^2050 in reference
[16]) and 5P-CCCCTGCTCTTAGGTGTC-3P (antisense strand, posi-
tions 2399^2416). The PCR program for cDNA products of rat origin
involved an initial denaturation step at 94‡C for 2 min, followed by
40 cycles of denaturation at 94‡C for 30 s, annealing at 60‡C for 1 min
and elongation at 68‡C for 2 min. For HIT-T15 cDNA product, the
following PCR program was carried out: initial denaturation cycle at
94‡C for 4 min, followed by 40 cycles at 92‡C, 58‡C and 72‡C each for
30 s. A ¢nal elongation step of 7 min at 68‡C (on rat cDNAs) and
2 min at 72‡C (on HIT-T15 cDNA), allowed to extend truncated
product to full-length. PCR reactions were performed using T£
DNA polymerase (Promega, Catalys AG, Wallisellen, Switzerland)
with 1 WM of each primer. Control experiments demonstrated that
ampli¢cation products were absent after reactions omitting reverse
transcriptase.
2.5. Production, puri¢cation and characterization of the RIM antibody
Approximately 500 Wg of GST-RIM fusion protein encoded by
pGEX-RIM-52 was injected into a rabbit (Eurogentech, Seraing, Bel-
gium). The immune response of the rabbit was tested by Western
blotting demonstrating that the serum reacted with the GST-RIM
protein whereas the pre-immune did not; similarly, immuno£uores-
cence using pre-immune serum showed no speci¢c plasma membrane
labelling. A⁄nity puri¢cation of the RIM antibody was performed by
incubating 1 ml of serum sample with 250 mg of protein A Sepharose
CL-4B (Sigma). After washing with PBS, the bound IgG was eluted
with 0.1 M glycine bu¡er pH 2.5 and desalted using centrifugal ¢lter
Centricon (Millipore, Geneva, Switzerland). Alternatively, the serum
was a⁄nity puri¢ed by binding GST and GST-RIM fusion proteins to
nitrocellulose ¢lters by preparative Western transfer; these immobi-
lized proteins were then used as absorbents to select antibodies spe-
ci¢c to RIM epitopes as described [17]. Before performing Western
blotting, the speci¢city of the antibody was tested by a competition
assay between a denatured GST-RIM protein and the protein A-pu-
ri¢ed a⁄nity antibody. A similar approach was also used before anal-
ysis of immuno£uorescence by incubating a native GST-RIM fusion
protein with the nitrocellulose a⁄nity-puri¢ed antibody.
2.6. Preparation of homogenates, GST-Rab3A Q81L binding assay and
Western blotting
Human and rat pancreatic islets, human and rat brain, rat kidney,
INS-1E, HIT-T15, BHK, COS and A431 cells (source of BHK, COS
and A431 cells: ATCC, Rockville, MD, USA) were washed twice with
ice-cold PBS and incubated for 10 min at 4‡C in homogenization
bu¡er (HB): 0.5% Triton X-100, 1 mM EDTA, 0.1 M NaCl, 0.1 g
l31 PMSF and 50 mM HEPES^NaOH, pH 7.4, and then disrupted by
brief sonication (3U1 s). The homogenates were centrifuged for 30
min at 4‡C at 14 000Ug and the supernatants were used in the binding
experiment or for Western blotting.
To perform the binding assay, glutathione Sepharose beads were
incubated with the GST-Rab3A Q81L fusion protein for 1 h at 4‡C
and washed ¢ve times in PBS, 5 mM EDTA and 0.5% Triton X-100.
The protein-coupled Sepharose beads were then incubated with
V1 mg of rat brain or kidney homogenates (prepared in HB), in
the presence of 100 WM GTP-QS at 4‡C overnight. After incubation
the samples were washed three times in 20 mM Tris^HCl pH 7.5,
1 mM EDTA, 6 mM MgCl2 and 1 mM DTT. The proteins remaining
attached to the beads were analyzed by Western blotting as previously
described [18].
2.7. Immuno£uorescence microscopy
To analyze the subcellular distribution of the endogenous RIM,
INS-1E and primary L-cells subcon£uent monolayers were rinsed in
PBS, ¢xed and permeabilized for 1 min in cold ethanol. The cells were
washed in PBS and were then incubated with the a⁄nity-puri¢ed
RIM antibody overnight at 4‡C. After rinsing with PBS, the cells
were exposed to a £uorescein isothiocyanate (FITC)-conjugated goat
anti-rabbit antibody. The coverslips were analyzed by confocal mi-
croscopy (Leica Lasertechnick, Heidelberg, Germany, model TCS
NT). Images were taken with a 40U objective.
The cytosolic localization of the RIM fragment in transfected INS-
1E cells was analyzed as described [9].
2.8. Cell culture, transient transfection and hGH release
The INS-1E cell clone [19] and the insulin-secreting cell line HIT-
T15 (kindly provided by R.F. Santerre and E. Lilly, INC, Indianap-
olis, USA) were cultured in RPMI 1640 medium supplemented with
10% FCS and other additions as described for each cell line [19,20].
For cotransfection experiments, INS-1E cells were seeded on poly-
ornithine-coated 24-well plates (2U105 cells per well) and transfected
3 days later. To this end, cells were washed with Mg2- and Ca2-free
PBS. 8 Wl of Lipofectamine (Life Technologies, Basel, Switzerland)
was complexed for 30 min with 2 Wg of pcDNA3-hGH encoding
human growth hormone (hGH), and 2 Wg of the mammalian expres-
sion plasmids (residues 1^399 of RIM and Rab3A Q81L mutant
cDNAs, inserted in the N-terminal myc-tagged pcDNA3) or the con-
trol vector myc-tagged pcDNA3 in 400 Wl RPMI 1640 medium con-
taining 10 mM HEPES. The mixture was added to the cells after
aspiration of PBS and exchanged for complete medium after 6 h.
Three days after transfection the cells were incubated at 37‡C for
2 h in complete medium without glucose and washed three times at
37‡C with modi¢ed Krebs^Ringer bicarbonate bu¡er (KRB) [8].
Thereafter cells were preincubated for 30 min in KRB containing
2.8 mM glucose and then incubated for 30 min in the same bu¡er
or KRB supplemented with 12.8 mM glucose. After incubation, se-
cretion from transfected cells was assessed by enzyme linked immu-
noabsorbent assay (ELISA) (Boehringer, Mannheim, Germany). Al-
ternatively, cells were permeabilized with K-toxin from Staphylococcus
aureus using intracellular bu¡ers as described [9].
3. Results and discussion
3.1. Expression of RIM in insulin-secreting cells
Fig. 1A illustrates the expression of RIM poly A RNA in
insulin-secreting hamster HIT-T15 cells and in rat insulinoma
INS-1E cells. Poly A RNA from rat brain was used as a
positive control. Two principal bands were observed corre-
sponding to approximately 8 kb and 12 kb in all three prep-
arations. These RNA species were not detectable when total
RNA was examined. Poly A RNA extracts of rat kidney,
hamster BHK and human A431 epidermoid cells [21] did not
reveal positive bands in Northern blotting under the condi-
tions used in Fig. 1A (data not shown). To date, there is no
published information on the RIM transcript. The expected
size of the coding mRNA for the published RIM sequence of
1553 amino acids [11] is 4659 bp. The observed bands of V8
kb and V12 kb suggest that these species contain 3P- or 5P-
untranslated regions (UTR). The two bands could represent
the two major alternatively spliced variants of the up to 18
proposed forms [11]. It is possible that several splicing var-
iants of similar size comigrate in the two bands, in particular
in the broader V8 kb.
Rat pancreatic islets contain at least 30% other cell types
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and therefore RT-PCR was performed on L-cells puri¢ed by
FACS (Fig. 1B). RT-PCR was also performed on RNA from
INS-1E cells and rat brain. The DNA sequencing of these
three ampli¢cation products con¢rmed the expression of
RIM. The database contains a partial coding sequence of
human brain mRNA. The encoded protein (Databank acces-
sion number AB002338; reference [22]) is 59% homologous to
the published rat brain RIM and is likely to correspond to a
human RIM splicing form. Indeed, we could amplify one
region from hamster HIT-T15 RNA conserved between rat
and human. The ampli¢cation of HIT-T15 cDNA using
PCR primers designed for regions speci¢c for the human or
the rat sequence did not yield positive signals (data not
shown).
To investigate the expression of the RIM protein, we used
the rabbit polyclonal antibody against RIM. The speci¢city of
the antibody was tested by several methods (see Section 2)
including its reactivity with proteins capable of binding
Rab3A in the GTP-bound form. Fig. 2A shows that the anti-
body reacts with a rat brain protein of V170 kDa complexed
to Rab3A-GTP. This protein was absent from rat kidney ex-
tract used as control.
Western blotting (Fig. 2B) revealed that rat brain, rat islets,
and INS-1E cells express similar quantities of a protein mi-
grating at V170 kDa. This molecular weight ¢ts well with the
published 1553 amino acids of the RIM alternatively spliced
variant [11]. The weak expression of the V170 kDa band in
HIT-T15 cells cannot be quantitatively compared before the
RIM sequence in hamster becomes available. The nature of
the minor bands of lower molecular weight (between 100 and
170 kDa) observed in Fig. 2B remains to be established. It
may be speculated that these proteins could represent several
spliced RIM variants of similar size or perhaps degradation
products. The immunoreactivity of V170 kDa was also
present in human brain (Fig. 2C). This band was not detected
in human islets. However the islets contained a major band
migrating with an Rf of V160 kDa as well as other proteins
of lower molecular weight. The complete sequence of the hu-
man RIM being unknown, the identity of these bands remains
only a speculation. Nonetheless, as aforementioned these pro-
teins may correspond to di¡erent RIM isoforms produced by
alternative splicing. Control extracts from rat kidney and
hamster BHK cells did not react with the antibody. Likewise
no positive bands were observed in monkey COS cells and in
human A431 epidermoid cells (data not shown). Taken to-
gether, these results demonstrate the presence of RIM in in-
sulin-secreting cells.
Fig. 1. Expression of RIM in insulin-secreting cells. A: Poly A
RNA from rat brain (RB), HIT-T15 (HIT) and INS-1E (INS) cells
were analyzed by Northern blotting. Based on the ethidium-bromide
staining and the spectrophotometric quantitation, similar amounts
(V2^3 Wg) of HIT-T15 and INS-1E mRNA were loaded on the
agarose gel. In order to obtain a similar intensity of the signal,
V0.5 Wg of brain mRNA was loaded. The molecular weight
markers are indicated. B: PCR ampli¢cation of RIM cDNA from
rat kidney (RK), rat brain (RB), rat islet L-cells (RI), INS-1E cells
(INS) and HIT-T15 cells (HIT). PCR reactions in which reverse
transcriptase was omitted are also shown (3). The sizes (bp) of the
ampli¢cation products are indicated by arrows.
Fig. 2. Western blotting of the homogenates. A: GTP-dependent
binding of RIM to GST-Rab3A Q81L. 1/4 of the volume of rat
kidney (RK) and rat brain (RB) binding assay was loaded on each
lane and immunoblotted with an antibody against RIM. B, C: Ex-
pression of RIM in insulin-secreting cells. Homogenates (100 Wg) of
rat kidney, rat brain, rat islet L-cells (RI), INS-1E (INS), HIT-T15
(HIT), BHK cells, human brain (HB), and human islets (HI) were
separated by SDS^PAGE, electroblotted and incubated with the
protein A-puri¢ed anti-RIM antibody (1:2000). The estimated mo-
lecular weight (kDa) of RIM is indicated by the arrow.
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3.2. Subcellular distribution of RIM
The cellular localization of RIM was examined by immuno-
£uorescence confocal microscopy. Fig. 3A shows that RIM is
mainly localized on the plasma membrane of rat islet L-cells
and the staining is found in patches. A similar distribution of
the protein is observed in INS-1E cells (Fig. 3C). Co-staining
with an anti-insulin antibody revealed that RIM is also ex-
pressed in islet endocrine cells not positive for insulin (data
not shown). By contrast, there was no plasma membrane re-
activity in rat hepatocytes and smooth muscle cells (data not
shown).
3.3. Role of soluble RIM in insulin exocytosis
The plasma membrane localization of RIM in insulin-se-
creting cells is compatible with a possible role in exocytosis.
To investigate the RIM function, the soluble Rab3A binding
N-terminal region of RIM was transiently overexpressed in
INS-1E cells. The cytosolic localization of the overexpressed
RIM fragment is shown in Fig. 4A using an anti-myc anti-
body.
The cDNAs encoding for the proteins under study were
cotransfected with human growth hormone (hGH) which
serves as a marker for exocytosis from the subpopulation of
Fig. 3. Subcellular localization of RIM by immuno£uorescence con-
focal microscopy. Pancreatic L-cells (A) and INS-1E cells (C) were
stained with the antibody against RIM and revealed using £uores-
cein-conjugated secondary antibody. The same cells were visualized
on phase contrast (B and D).
Fig. 4. Immunolabelling of transfected soluble RIM fragment in
INS-1E cells. INS-1E cells transiently transfected with the myc-
tagged N-terminal region of RIM were analyzed by confocal mi-
croscopy after immuno£uorescence with an antibody against the
myc epitope (revealed using £uorescein-conjugated antibodies) (A).
The same cells were visualized on phase contrast (B).
Fig. 5. E¡ect of Rab3A Q81L and the N-terminal domain of RIM
on exocytosis in intact and K-toxin permeabilized INS-1E cells. A:
INS-1E cells were transiently cotransfected with a plasmid encoding
human growth hormone (hGH) as a reporter for secretion, and
with respectively the control vector pcDNA3 (control), the mutant
Rab3A Q81L (Q81L) or the N-terminal region of RIM (residues 1^
399) (RIM). The latter cDNA was also cotransfected with Rab3A
Q81L (Q81L+RIM). After 3 days, the cells were incubated in the
presence of 2.8 mM glucose or with 12.8 mM glucose for 30 min.
The cells were then collected and the expression of the exogenous
proteins was analyzed by Western blotting using an antibody
against the myc epitope (c-myc). One representative experiment is
shown at the top. The amount of hGH secreted by the cells in re-
sponse to the stimuli was measured by ELISA. The basal secretion
rates ranged from 16 to 27 pg/well. The hGH cellular content rates
ranged from 484 to 502 pg/well. The lower panel shows the mean þ
S.E.M. of three independent experiments performed in duplicate.
B: Three days after transfection the cells were permeabilized with
K-toxin for 10 min and subsequently exposed to 0.1 WM Ca2 or
10 WM Ca2 during 10 min. The basal secretion rates ranged from
32 to 41 pg/well. The results represent the mean þ S.E.M. of two in-
dependent experiments performed in triplicate.
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transfected cells [9,23]. Fig. 5A shows that an increase in the
glucose concentration from 2.8 to 12.8 mM, caused a 4.7-fold
increase in hGH release. As reported previously for transi-
ently transfected HIT-T15 cells [8,9], overexpression of the
GTPase de¢cient mutant (Rab3A Q81L) inhibited the stimu-
lated secretion by 41%. Transfection of the soluble N-terminal
domain of RIM enhanced stimulated exocytosis by 75%, while
basal secretion was una¡ected (Fig. 5A, legend). The com-
bined expression of Rab3A Q81L and RIM completely neu-
tralized the e¡ect of RIM on exocytosis (100% of control).
The observed changes in the secretory responses are not due
to varying degrees of overexpression of RIM or Rab3A Q81L
as shown by Western blotting using an anti-myc antibody
(Fig. 5A, upper panel), or to variations in the hGH content
(Fig. 5A, legend). The results obtained with the GTPase de¢-
cient mutant Rab3A Q81L indicate an in vivo interaction
between RIM and the GTP-bound form of Rab3A as sug-
gested previously [11].
To investigate whether RIM acts by increasing the Ca2
signalling pathway or by directly enhancing the exocytotic
process, we performed experiments in K-toxin permeabilized
cells, to bypass the function of ion channels and other plasma
membrane events. Ca2 (10 WM) stimulated exocytosis 1.9-
fold (Fig. 5B). Rab3A Q81L inhibited the release by 35%
whereas RIM augmented the secretion by 78%. Again, the
stimulant action of RIM was reversed by the Rab3A mutant
(106% of control). These data clearly show that RIM acts
directly on the exocytotic process without a¡ecting upstream
signalling. The results obtained with the soluble domain of
RIM both in intact and in permeabilized cells, strongly sug-
gest that the overexpressed fragment increases exocytosis by
interfering with the normal function of Rab3.
3.4. Conclusions
Our results demonstrate that RIM is not only neuron spe-
ci¢c but is also expressed in native pancreatic L-cells and
derived cell lines. The protein is localized at the plasma mem-
brane of the endocrine cell types. The observed e¡ects of RIM
overexpression on exocytosis further substantiate the model
proposed for neuro-exocytosis [11]. Hence, the insulin-con-
taining secretory granule would be clamped by the interaction
of Rab3-GTP on its surface with RIM at the plasma mem-
brane close to L-type Ca2 channels [24,25]. Recently, func-
tional interaction between the exocytotic machinery and this
type of voltage-sensitive Ca2 channel was reported [25]. Fol-
lowing membrane depolarization by glucose and other secre-
tagogues, the Ca2 concentration increases. The subsequent
binding of Ca2 to calmodulin dissociates Rab3 from the
secretory granule [26] as demonstrated for PC12 cells and
HIT-T15 cells recently [23]. This allows exocytosis to proceed
at the site determined by the localization of RIM.
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